Ameriprise Financial Inc. Raises Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Ameriprise Financial Inc. boosted its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 9.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 70,935 shares of the medical instruments supplier's stock after purchasing an additional 6,312 shares during the period. Ameriprise Financial Inc. owned about 0.34% of Mettler-Toledo International worth $86,802,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. JPMorgan Chase & Co. lifted its position in Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after purchasing an additional 28,478 shares in the last quarter. Allworth Financial LP raised its stake in shares of Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock worth $285,000 after buying an additional 169 shares during the period. Robeco Institutional Asset Management B.V. lifted its position in shares of Mettler-Toledo International by 18.0% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after buying an additional 5,234 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its stake in shares of Mettler-Toledo International by 773.3% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier's stock valued at $6,530,000 after acquiring an additional 4,725 shares during the period. Finally, Impax Asset Management Group plc increased its holdings in Mettler-Toledo International by 5.8% in the 4th quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier's stock worth $243,331,000 after acquiring an additional 10,830 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on MTD. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their price target for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. StockNews.com downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Citigroup raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a report on Monday, April 7th. Wells Fargo & Company upped their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Finally, Evercore ISI lifted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $1,296.13.

Mettler-Toledo International Stock Performance

Shares of MTD traded down $21.67 during mid-day trading on Friday, hitting $1,079.96. 133,782 shares of the stock were exchanged, compared to its average volume of 145,671. The company has a market cap of $22.44 billion, a PE ratio of 26.65, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. Mettler-Toledo International Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The firm has a 50-day moving average of $1,118.64 and a two-hundred day moving average of $1,222.96.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. During the same quarter last year, the business earned $8.89 earnings per share. Mettler-Toledo International's quarterly revenue was down 4.6% compared to the same quarter last year. On average, sell-side analysts predict that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the business's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 600 shares of the company's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. This represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.